1.
The HTA Network shall be chaired by the Commission representative. The chair person shall not vote.
2.
Commission officials with an interest in the proceedings may attend meetings of the HTA Network and its working groups.
3.
Upon request of the Commission, the European Medicines Agency may participate in meetings of the HTA Network and its working groups.
4.
The HTA Network may invite European and international organisations to attend meetings as observers.